Navigation Links
Reportlinker Adds Active Pharmaceutical Ingredients (APIs) Market to 2015 - Rise in the Generic and Biotech Sector will Sustain Growth
Date:10/12/2010

re Analysis by Product Type Based on Customer Base, %, 2009 and 2015 88

Table 55: API Market, China, Revenue Share Analysis by Therapeutic Category, %, 2009 90

Table 56: API Market, India, Revenues, $m, 2005–2015 91

Table 57: API Market, India, Revenue Share Analysis by Product Type Based on Synthesis Route, %, 2009 and 2015 92

Table 58: API Market, India, Revenue Share Analysis by Product Type Based on Customer Base, %, 2009 and 2015 93

Table 59: API Market, India, Revenue Share Analysis by Therapeutic Category, %, 2009 95

Table 60: API Market, South and Central America, Revenues, $m, 2005–2015 98

Table 61: API Market, South and Central America, Revenue Share Analysis by Product Type Based on Synthesis Route, %, 2009 and 2015 99

Table 62: API Market, South and Central America, Revenue Share Analysis by Product Type Based on Customer Base, %, 2009–2015 99

Table 63: API Market, South and Central America, Revenue Share Analysis by Country, %, 2009–2015 100

Table 64: API Market, Mexico, Revenues, $m, 2005–2015 102

Table 65: API Market, Mexico, Revenue Share Analysis by Product Type Based on Synthesis Route, %, 2009 and 2015 103

Table 66: API Market, Mexico, Revenue Share Analysis by Product Type Based on Customer Base, %, 2009 and 2015 104

Table 67: API Market, Mexico, Revenue Share Analysis by Therapeutic Category, %, 2009 106

Table 68: API Market, Brazil, Revenues, $m, 2005–2015 108

Table 69: API Market, Brazil, Revenue Share Analysis by Product Type Based on Synthesis Route, %, 2009 and 2015 109

Table 70: API Market, Brazil, Revenue Share Analysis by Product Type Based on Customer Base, %, 2009 and 2015 109

Table 71: API Market, Brazil, Revenue Share Analysis by Therapeutic Category, %, 2009 111

1.2 List of FiguresFigure 1: API, Global, Industry Value Chain, 2009 13

Figure 2: API Market, Global, R
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related medicine technology :

1. Reportlinker Adds Imaging Diagnostics Market in Poland 2010 - Development Forecasts for 2010-2012
2. Reportlinker Adds European RIS/PACS Market
3. Reportlinker Adds U.S. Venous Access Catheter Market
4. Reportlinker Adds Pharmaceutical Contract Manufacturing: Industry and Market Prospects 2010-2025
5. Reportlinker Adds Merger and Acquisition Terms and Agreements in Pharma, Biotech and Diagnostics, 4th edition
6. Reportlinker Adds Co-promotion and Co-marketing Agreements in Pharma, Biotech and Diagnostics, 4th Edition
7. Reportlinker Adds Global Vertebral Compression Fracture Devices Industry
8. Reportlinker Adds Nanobiotechnologies - Applications, Markets and Companies
9. Reportlinker Adds US Pharmaceutical Market Overview - Healthcare reform, economic pressures and the patent cliff set to impact Pharma
10. Reportlinker Adds Antidiabetics Market Forecast
11. Reportlinker Adds Global Anti-CD20 Monoclonal Antibodies Industry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... EVANSTON, Ill. , Nov. 21, 2014  Heated ... prescription drug prices – from cancer treatments to Gilead,s ... and pharmaceutical leaders around the world questioning what it ... quality of care. And while drug ... the pharmaceutical industry – from both a general business ...
(Date:11/21/2014)... Clementia Pharmaceuticals, Inc.  announced ... has granted Orphan Medicinal Product Designation for ... the treatment of fibrodysplasia ossificans progressiva (FOP). ... disease characterized by painful, recurrent episodes of ... bone formation. This process, known as heterotopic ...
(Date:11/21/2014)... , Nov. 20, 2014 /PRNewswire/-- CANTEL MEDICAL CORP. (NYSE: ... Chief Executive Officer, will be presenting at the 26 th ... Palace Hotel in New York . The ... 2:00 PM ET. In addition, Mr. Krakauer and Jorgen ... separate one-on-one meetings during the day. An ...
Breaking Medicine Technology:"The Price of Global Health" Tackles Worldwide Drug-Pricing Debate 2"The Price of Global Health" Tackles Worldwide Drug-Pricing Debate 3"The Price of Global Health" Tackles Worldwide Drug-Pricing Debate 4"The Price of Global Health" Tackles Worldwide Drug-Pricing Debate 5Clementia Pharmaceuticals Receives EMA Orphan Medicinal Product Designation for Palovarotene for the Treatment of Fibrodysplasia Ossificans Progressiva 2Clementia Pharmaceuticals Receives EMA Orphan Medicinal Product Designation for Palovarotene for the Treatment of Fibrodysplasia Ossificans Progressiva 3
... - IgG1 monoclonal,antibodies developed by ImClone Systems ... total presentations at the recently concluded,98th Annual ... Research,(AACR), including seven oral presentations and 37 ... the focus of,two back-to-back oral presentations leading ...
... ANGELES--(BUSINESS WIRE)--Apr 19, 2007 - Abraxis ... discussed results from two pre-clinical studies ... and,rationale for combining nab-paclitaxel (ABRAXANE(R) for ... (albumin-bound)) with VEGF inhibitor drugs like,bevacizumab ...
Cached Medicine Technology:ImClone Systems Showcases Extensive Research and Development,Program at the AACR Annual Meeting 2ImClone Systems Showcases Extensive Research and Development,Program at the AACR Annual Meeting 3ImClone Systems Showcases Extensive Research and Development,Program at the AACR Annual Meeting 4ImClone Systems Showcases Extensive Research and Development,Program at the AACR Annual Meeting 5Abraxis BioScience Presents Data from Pre-Clinical Study That,Provide Evidence for Chemotherapy-Induced Angiogenesis and,Rationale for Combining nab-Paclitaxel (Abraxane) with,Anti-Angiogenic Agents to Increase Tumor Response 2Abraxis BioScience Presents Data from Pre-Clinical Study That,Provide Evidence for Chemotherapy-Induced Angiogenesis and,Rationale for Combining nab-Paclitaxel (Abraxane) with,Anti-Angiogenic Agents to Increase Tumor Response 3Abraxis BioScience Presents Data from Pre-Clinical Study That,Provide Evidence for Chemotherapy-Induced Angiogenesis and,Rationale for Combining nab-Paclitaxel (Abraxane) with,Anti-Angiogenic Agents to Increase Tumor Response 4Abraxis BioScience Presents Data from Pre-Clinical Study That,Provide Evidence for Chemotherapy-Induced Angiogenesis and,Rationale for Combining nab-Paclitaxel (Abraxane) with,Anti-Angiogenic Agents to Increase Tumor Response 5
(Date:11/21/2014)... CA (PRWEB) November 21, 2014 ... creating picture-perfect smiles for patients in preparation for the ... to the fronts of teeth, look completely natural, and ... certain situations, veneers are also valued for their ability ... patients and can be used on one or several ...
(Date:11/21/2014)... 2014 (HealthDay News) -- The cost of diabetes care ... recent years, climbing to more than $322 billion annually, ... cost were seen with prediabetes care, which have risen ... percent, the researchers added. In 2012, excess medical ... than $1,000 for every American. That total includes $244 ...
(Date:11/21/2014)... November 21, 2014 Richard Wolfe, ... , will present advanced benefits administration strategies during ... Houston HR Leadership Summit. This Game Changer breakout ... industry to present cutting-edge solutions and best practices ... explain how real-time data exchange between health and ...
(Date:11/21/2014)... Saint Luke’s Mid America Heart ... Failure Gold-Plus Quality Achievement Award for implementing specific ... Association/American College of Cardiology Foundation in their secondary ... With The Guidelines–Heart Failure is a quality improvement ... up-to-date, research-based guidelines with the goal of speeding ...
(Date:11/21/2014)... November 21, 2014 The typical Thanksgiving ... calorie dishes, plenty of gravy and a myriad of ... the best time of year to begin losing weight? ... has uncovered the secret to losing unhealthy, embarrassing and ... holiday recipes. , The insight to Diet Doc’s calorie ...
Breaking Medicine News(10 mins):Health News:Los Angeles Porcelain Veneers Dentist, Dr. Kevin Sands, Now Creates Picture-Perfect Smiles for Patients for the Holiday Season 2Health News:Cost of Diabetes Care Keeps Climbing, Report Shows 2Health News:Empyrean Benefit Solutions CEO Sharing Latest Benefits Administration Strategies with Houston HR Leaders 2Health News:Empyrean Benefit Solutions CEO Sharing Latest Benefits Administration Strategies with Houston HR Leaders 3Health News:Saint Luke’s Mid America Heart Institute Awarded Get With The Guidelines Heart Failure Gold-Plus Quality Achievement Award 2Health News:Saint Luke’s Mid America Heart Institute Awarded Get With The Guidelines Heart Failure Gold-Plus Quality Achievement Award 3Health News:Saint Luke’s Mid America Heart Institute Awarded Get With The Guidelines Heart Failure Gold-Plus Quality Achievement Award 4Health News:Diet Doc Releases New Calorie Loading Diet Plans - the Perfect Way to Jump Start the Metabolism and Begin Weight Loss During Thanksgiving 2Health News:Diet Doc Releases New Calorie Loading Diet Plans - the Perfect Way to Jump Start the Metabolism and Begin Weight Loss During Thanksgiving 3Health News:Diet Doc Releases New Calorie Loading Diet Plans - the Perfect Way to Jump Start the Metabolism and Begin Weight Loss During Thanksgiving 4
... in this group , WEDNESDAY, June 2 (HealthDay News) -- ... of developing prostate cancer than white men, but now a ... likely to develop aggressive forms of the disease. , Researchers ... whites -- whose prostates were removed at the Durham Veterans ...
... ... maker of the life’sDHA™ brand, Martek Biosciences Corporation (NASDAQ: MATK) announced today that Norman ... selected as the recipient of the Alex Leaf Distinguished Scientist Award for 2010. ... Columbia, Md. (Vocus) ...
... ... in the last several years. ,Global Launch Management, a product launch management company, offers ... traditional marketing, the product launch marketing model has been very successful for many 60 ... ...
... say , WEDNESDAY, June 2 (HealthDay News) -- A ... for a kind of brain tumor in children, researchers report. ... 20 percent of childhood brain cancer cases. Treatment, which can ... at five years to 70 percent, but the tumors remain ...
... donations have more than doubled since the institution of grassroots ... published in the May issue of the Journal of ... of minority donors is expected to reach 35 percent, up ... organ transplant in 1954, the shortage of organ donors has ...
... reporting new evidence that capsaicin, the stuff that gives chili ... buildup by triggering certain beneficial protein changes in the body. ... appears in ACS, monthly Journal of Proteome Research . ... obesity is a major public health threat worldwide, linked to ...
Cached Medicine News:Health News:Martek Biosciences Chief Scientific Officer, Dr. Norman Salem, 2010 Recipient of ,Alex Leaf Distinguished Scientist Award 2Health News:Martek Biosciences Chief Scientific Officer, Dr. Norman Salem, 2010 Recipient of ,Alex Leaf Distinguished Scientist Award 3Health News:Traditional Marketing is Dead! GLM Creates a Sales Spike in Under 60 Days Stops Business Failure; Provides Startup Funding 2Health News:Grassroots programs to encourage minority organ donation prove successful 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: